Vaspin (human) ELISA Kit

Serum vaspin concentrations in human obesity and type 2 diabetes: B.S. Youn, et al.; Diabetes 57, 372 (2008)

Serum levels of the adipokine vaspin in relation to metabolic and renal parameters: J. Seeger, et al.; J. Clin. Endocrinol. Metab. 93, 247 (2008)

Metformin decreases the Adipokine Vaspin in overweight women with the polycystic ovary syndrome: Concomitant improvement in insulin sensitivity and a decrease in insulin resistance: B.K. Tan, et al.; Diabetes 57, 1501 (2008)

Vaspin: a novel serpin with insulin-sensitizing effects: J. Wada; Expert Opin. Investig. Drugs 17, 327 (2008)

Vaspin serum concentrations in patients with carotid stenosis: G. Aust, et al.; Atherosclerosis 204, 262 (2009)

Serum vaspin levels in type 2 diabetic women in relation to microvascular complications: N.E. Gulcelik, et al.; Eur. J. Endocrinol. 160, 65 (2009)

Serum Visceral Adipose Tissue–Derived Serine Protease Inhibitor Concentrations in Human Obesity and Polycystic Ovary Syndrome: H.F. Escobar-Morreale, et al.; Diabetes Care 32, e6 (2009)

Low-dose pioglitazone and low-dose flutamide added to metformin and oestro-progestagens for hyperinsulinaemic women with androgen excess: add-on benefits disclosed by a randomized double-placebo study over 24 months: L. Ibanez, et al.; Clin. Endocrinol. (Oxf) 71, 351 (2009)

Preliminary report: circulating levels of the adipokine vaspin in gestational diabetes mellitus and preeclampsia: H. Stepan, et al.; Metabolism 59, 1054 (2010)

Circadian Rhythm of Serum Vaspin in Healthy Male Volunteers: Relation to Meals: E. Jeong, et al.; J. Clin. Endocrinol. Metab. 95, 1869 (2010)